D59.30
Hemolytic-uremic syndrome, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Hemolytic-uremic syndrome NOS
Medical Intelligence & Overview
Hemolytic-uremic syndrome (HUS) is a serious condition that primarily affects the blood and kidneys. When the specific cause isn't clear or falls outside identified categories, it is classified as unspecified HUS under ICD-10 code D59.30. This condition mainly impacts children but can also occur in adults. Recognizing the signs and understanding the underlying issues can be crucial for timely medical intervention.
Causes & Symptoms
Clinical Causes: Infection, particularly with certain bacteria like E. coli (especially strain O157:H7) Use of certain medications or toxins Underlying genetic conditions affecting blood clotting or the immune system Other illnesses or infections that trigger an abnormal immune response Unknown factors when the exact cause cannot be identified
Key Symptoms: Low red blood cell count (anemia), leading to fatigue and pallor Bruising or bleeding due to low platelets Decreased urine output or dark-colored urine Swelling in the face, arms, legs, or abdomen High blood pressure Fever, nausea, vomiting, or abdominal pain
Diagnostic & Treatment
Diagnosis Path: Diagnosing HUS involves a combination of medical history, physical examination, and laboratory tests. Blood tests can reveal anemia, low platelet count, and signs of hemolysis. Urinalysis can detect kidney impairment, and stool tests might identify bacterial infection sources. Imaging studies like ultrasound may be used to assess kidney health.
Treatment Protocols: Management of HUS requires prompt medical attention and may involve hospitalization. Treatment strategies focus on supporting affected organs and preventing complications. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is D59.30 a billable ICD-10 code?
Yes, D59.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D59.30?
Clinical documentation must specify the nature of Hemolytic-uremic syndrome, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference